|
Results of the survey - Reproductive Immunology Practice in IVF | ||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||
In Summary:
It is stimulating to know that the majority of physicians think that the understanding and use of the principles of reproductive immunology is important for human reproduction. The majority of physicians are getting the reproductive immunology information through academic press or journals, although 10% reported no resources. Two thirds of physicians think reproductive immunology update is not easy to obtain through IVF network or society.
It is interesting to know that genetic, thrombophilic and reproductive immunology evaluations are often considered by IVF physicians when IVF candidates have a history of recurrent pregnancy losses (RPL) or chemical pregnancy losses.
Over half of physicians approach recurrent implantation failures (RIF) in the same way as RPL. Immunological assessments are considered most often after two failed IVF cycles.
Evaluation patterns for RPL and RIF are similar however, the frequencies for individual test for RPL tend to be more than those for RIF. It seems that physicians are more eager to evaluate immunological abnormalities or thrombophilia in women with RPL than RIF.
Prof. Joanne Kwak-Kim and Prof. Simon Fishel, If you have any questions or comments please contact us via email at
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Prof. Zeev Shoham and Prof. Milton Leong | ||||||||||||||||||||||||||||||||||||||||||

